The unfortunate situation created by this Coronavirus pandemic is providing a serious opportunity for reassessing the current regulatory approaches in pharmaceutical products development and their manufacturing so that such irrelevant discussion can be avoided and patients can have access to modern and multiple options to treat ailments. Hopefully, in the future, patients will be treated with well-established products rather than products developed on the fly or with the use of disposable gowns, masks, washing hands and/or staying home policy which certainly is not the treatment. Patients expect and deserve something better from us as scientists, physicians, and regulators. Follow the link for the complete article (link)